Log in to save to my catalogue

miR- 26a Sensitizes Melanoma Cells To Dabrafenib Via Targeting HMGBI-Dependent Autophagy Pathways

miR- 26a Sensitizes Melanoma Cells To Dabrafenib Via Targeting HMGBI-Dependent Autophagy Pathways

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A606172797

miR- 26a Sensitizes Melanoma Cells To Dabrafenib Via Targeting HMGBI-Dependent Autophagy Pathways

About this item

Full title

miR- 26a Sensitizes Melanoma Cells To Dabrafenib Via Targeting HMGBI-Dependent Autophagy Pathways

Publisher

Dove Medical Press Limited

Journal title

Drug design, development and therapy, 2019-10, p.3717

Language

English

Formats

Publication information

Publisher

Dove Medical Press Limited

More information

Scope and Contents

Contents

Background: Melanoma is known as the most aggressive and lethal type of cutaneous cancer due to its rapid development of drug resistance to chemotherapy drugs. Methods: In our study, we conducted a variety of studies, including quantitative PCR, Western blot, and autophagy and apoptosis assays to investigate the involvement of miR-26a and HMGB1 in...

Alternative Titles

Full title

miR- 26a Sensitizes Melanoma Cells To Dabrafenib Via Targeting HMGBI-Dependent Autophagy Pathways

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A606172797

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A606172797

Other Identifiers

ISSN

1177-8881

E-ISSN

1177-8881

DOI

10.2147/DDDT.S225671

How to access this item